Rare Disease Foundation Partners With Citizen Health to Embed AI Agent Into Daily Care

A rare disease foundation has partnered with Citizen Health, a health data and AI-driven care platform, to embed an AI agent into the daily care of rare disease patients, according to a report by Fierce Healthcare. The partnership marks a significant expansion of AI applications from diagnostic support to ongoing care management.

Citizen Health specializes in aggregating patient medical records, genomic data, and daily health information to deliver personalized care recommendations for chronic and rare disease patients. By working with the rare disease foundation, the company aims to bring AI agent capabilities directly into patients' everyday care workflows.

Rare disease patients have long faced challenges including fragmented medical information, scarce specialist resources, and lack of care continuity. An AI agent embedded in daily care could help patients better manage symptoms, track medication adherence, access disease-related knowledge, and connect with healthcare resources when needed. For the foundation, this represents a technology-driven approach to expanding service reach and improving patient engagement efficiency.

While AI has already been deployed across medical imaging, drug discovery, and health monitoring, embedding AI agents directly into patients' daily care management remains a relatively new frontier. This partnership extends AI agents from hospital settings into home-based health management, potentially paving the way for more AI-powered health management solutions targeting chronic and rare disease communities.

As AI agents continue to penetrate healthcare, ensuring data privacy, clinical accuracy, and regulatory compliance remains a central concern. The partnership between the foundation and Citizen Health is expected to proceed within established compliance frameworks.